Skip to main content
. 2018 Apr 30;9:427. doi: 10.3389/fphar.2018.00427

Figure 3.

Figure 3

Comparison of plasma RST concentration between control group and CI-AKI group in patients without CKD (A), in patients with CKD (B), and in all patients (C) in stage II. ROC analyses of variables for predicting CI-AKI in patients without CKD (D), in patients with CKD (E), and in all patients (F) in stage II. DM-RST: N-desmethyl rosuvastatin, RST: rosuvastatin; other abbreviations as in Figures 1, 2.